LIMA1 / LIM domain and actin-binding protein 1 · Western blot design guide

Design a Western Blot for LIMA1

Source-linked LIMA1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-LIMA1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for LIMA1: expected band ~85.2 kDa, hero antibody A05231, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable LIMA1 Western blot protocol sheet — expected band ~85.2 kDa, antibody A05231, controls and PMC citations. Open the full LIMA1 WB guide →

LIMA1 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~85.2 kDa
Gel 8–10% (standard starting point)
Positive control ⓘ Appendix (IHC candidate; verify WB) +4 more
Negative control ⓘ Caudate (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Phosphorylated + Acetylated
Caveat Phosphorylation-state controls
Gene-set association MSigDB Hallmark membership
Isoform 5 isoform(s)
Section 1

Source-Linked LIMA1 Western Blot Protocol Options

The A05231 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman colon tissue lysate (catalog A05231)
Gel %8–10% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferStandard semi-dry transfer; verify efficiency (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA05231 · (A) 0.5 and (B) 1 μg/ml (catalog A05231)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected LIMA1 Western Blot Band Size?

LIMA1 has a predicted mass of 85.2 kDa; isoforms could affect band patterns, but no empirical migration is supplied.

What am I looking at on my blot?
Band near 85.2 kDaConsistent with the predicted LIMA1 mass; confirm identity with controls
Several bands at different positionsCould reflect the five annotated isoforms; their migration is unverified
Close doubletCould reflect isoforms or phosphorylation; neither pattern is established
Band enriched in a cytoskeletal fractionConsistent with LIMA1's cytoskeletal localization
💡Expected LIMA1 appearanceUniProt predicts 85.2 kDa for LIMA1, but no empirical band size is supplied; confirm any candidate band with antibody and depletion controls because isoform migration is unknown.
How each factor affects band size
UniProt predicted massProvides an 85.2 kDa reference, not a measured band position
Beta and Alpha isoformsMay differ in apparent size; individual masses are unavailable
Isoform 3May differ in apparent size; its mass is unavailable
Isoforms 4 and 5May differ in apparent size; individual masses are unavailable
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateCytoskeleton-associated LIMA1 may be poorly recovered during extractionCheck insoluble fractions and compare extraction conditions
Band higher than expectedAn isoform or altered migration is possible; the cause is unestablishedCompare antibody reagents and use LIMA1 depletion to test identity
Band lower than expectedAn isoform is possible; no isoform mass is suppliedConfirm identity with LIMA1 depletion and an antibody to another epitope
Multiple bandsFive isoforms are annotated, but their band positions are unknownCompare isoform expression and test which bands disappear after LIMA1 depletion
Weak or no signalExtraction may underrecover cytoskeleton-associated LIMA1Check fraction recovery and include a validated positive lysate

Sample controls for LIMA1 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for LIMA1 in Western blot, you can use appendix tissue, which shows high expression in HPA.
Positive control: Appendix (IHC candidate; verify WB)
Negative control: Caudate (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: Intracellular localization and an HPA not-detected tissue make tissue-based controls feasible.

HPA tissue expression evidence for LIMA1

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Appendix endocrine cells High Protein (IHC) HPA →
Breast glandular cells High Protein (IHC) HPA →
Cervix glandular cells High Protein (IHC) HPA →
Colon endocrine cells High Protein (IHC) HPA →
Duodenum endocrine cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Caudate glial cells Not detected Protein (IHC) HPA →
Cerebral cortex endothelial cells Not detected Protein (IHC) HPA →
Heart muscle cardiomyocytes Not detected Protein (IHC) HPA →
Hippocampus glial cells Not detected Protein (IHC) HPA →
Liver cholangiocytes Not detected Protein (IHC) HPA →
Section 3

Advanced LIMA1 Western Blot Tips

Deeper troubleshooting and optimisation questions for LIMA1, answered from its protein features.

How should LIMA1 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could LIMA1 isoforms produce different bands?
Isoforms · Yes. Five isoforms are listed. Isoform 3 lacks residues 1–302; Alpha and 5 lack residues 1–160. Compare each band with the isoforms your antibody can recognize before assigning it. The supplied features do not establish their apparent band positions.

Yes. An antibody recognizing residues 1–160 would miss Alpha and isoform 5, while one recognizing residues 1–302 would miss isoform 3. Check the antibody's stated target region against these UniProt sequence changes before comparing isoform bands.
Could phosphorylation explain a shifted LIMA1 band?
PTM · UniProt lists phosphorylation, including Ser225, Tyr229, Ser230 and Ser601/604/609/617. These sites make phosphorylation worth considering when comparing bands across samples, but their presence alone does not establish a visible shift or explain a difference from 85.2 kDa. Keep UniProt numbering distinct from any antibody or paper numbering.
Does this guide establish induction of LIMA1?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for LIMA1?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A05231 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should I quantify LIMA1 across samples?
Quantitation · Define which band you will measure and use the same band definition across samples. Five isoforms are listed, and LIMA1 is annotated in the cytoplasm, cytoskeleton, focal adhesions and at the cell membrane. Keep the sampled fraction consistent when comparing abundance.
What size band should I expect for LIMA1?
Interpretation · The supplied 759-residue sequence has a predicted mass of 85.2 kDa. No observed Western blot band is provided, so use 85.2 kDa as a starting reference, not an established apparent mass.

Check whether an extra band is compatible with the listed isoforms: isoform 3 lacks residues 1–302, Alpha and 5 lack 1–160, and isoforms 4 and 5 have an R-to-PG change at UniProt position 344. The features alone cannot identify an observed band or prove that a modification caused it.
Boster reagents

LIMA1 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of LIMA1 in human colon tissue lysate with LIMA1 antibody at (A) 0.5 and (B) 1 μg/ml.
Anti-LIMA1 Antibody
Cat # A05231
Real WB data Western blot analysis of EPLIN/LIMA1 using anti-EPLIN/LIMA1 antibody (A05231-1). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human Hela whole cell lysates, Lane 2: human HepG2 whole cell lysates, Lane 3: human 293T whole cell lysates, Lane 4: human T-47D whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-EPLIN/LIMA1 antigen affinity purified polyclonal antibody (Catalog # A05231-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for EPLIN/LIMA1 at approximately 85 kDa and 100 kDa. The expected band size for EPLIN/LIMA1 is at 85 kDa.
Anti-EPLIN/LIMA1 Antibody Picoband®
Cat # A05231-1

Both listed anti-LIMA1 antibodies are reported as human-reactive and have Western blot images. A05231 was tested on human colon tissue lysate; A05231-1 was tested on four human cell lines, with reported bands near 85 and 100 kDa. Evidence is limited to these reported samples.

Which to pick: Choose A05231 for a human colon tissue lysate precedent, or A05231-1 for a human cell lysate precedent (HeLa, HepG2, 293T, or T-47D). Both have WB images; the reported sample and conditions are the useful distinction.

Source: BosterBio LIMA1 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.